Spots Global Cancer Trial Database for operable breast cancer
Every month we try and update this database with for operable breast cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sentinel Node Biopsy and Axillary Sampling in Operable Breast Cancer | NCT00128362 | Cancer of the B... | Radio-guided se... Axillary sampli... | 18 Years - 70 Years | Tata Memorial Hospital | |
Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer | NCT05114720 | Breast Cancer | standard adjuva... standard adjuva... | 18 Years - 70 Years | Sun Yat-sen University | |
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center | |
Capecitabine in Women With Operable Breast Cancer | NCT00148720 | Invasive Breast... Primary Invasiv... Stage I Breast ... Stage II Breast... Stage III Breas... | Capecitabine | 18 Years - | Dana-Farber Cancer Institute | |
A Study of Liposomal Doxorubicin + Docetaxel + Trastuzumab + Metformin in Operable and Locally Advanced HER2 Positive Breast Cancer | NCT02488564 | HER-2 Positive ... | Liposomal doxor... Docetaxel Trastuzumab Metformin | 18 Years - 75 Years | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | NCT00038402 | Breast Cancer | Herceptin Taxol Fluorouracil Cytoxan Epirubicin | - | M.D. Anderson Cancer Center | |
Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer | NCT01916317 | Operable Breast... | 0.5% lignocaine... | 18 Years - 99 Years | Tata Memorial Hospital | |
Muscle Parameters and Pathological Response in Breast Cancer Patients | NCT06151379 | Neoadjuvant Che... | Neoadjuvant the... | 29 Years - 72 Years | Acıbadem Atunizade Hospital | |
Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer | NCT05114720 | Breast Cancer | standard adjuva... standard adjuva... | 18 Years - 70 Years | Sun Yat-sen University | |
Muscle Parameters and Pathological Response in Breast Cancer Patients | NCT06151379 | Neoadjuvant Che... | Neoadjuvant the... | 29 Years - 72 Years | Acıbadem Atunizade Hospital | |
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center | |
Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer | NCT00050167 | Breast Cancer | Paclitaxel Docetaxel Capecitabine | - | M.D. Anderson Cancer Center |